GB715976A - Improvements in medical preparations for removing toxic heavy metals from the human body - Google Patents

Improvements in medical preparations for removing toxic heavy metals from the human body

Info

Publication number
GB715976A
GB715976A GB6305/52A GB630552A GB715976A GB 715976 A GB715976 A GB 715976A GB 6305/52 A GB6305/52 A GB 6305/52A GB 630552 A GB630552 A GB 630552A GB 715976 A GB715976 A GB 715976A
Authority
GB
United Kingdom
Prior art keywords
acetic acid
tetra
solution
diamino
ethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6305/52A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB715976A publication Critical patent/GB715976A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pyrogen-free aqueous solution of a sodium or potassium salt of a calcium chelate compound of an alkylene-polyamine polyacetic acid at pH 7.2-7.4 is used for medical injection. Diamine tetra-acetic acids mentioned are ethylene diamine tetra-acetic acid, trimethylene diamine tetra-acetic acid, propylene diamine tetra-acetic acid, 1,2-cyclohexylene diamino N,N-tetra-acetic acid, diethyl ether b,b1-diamino N,N1-tetra-acetic acid, ethylene glycol 1,2-ethylene ether o ,o 1, diamino N,N1, tetra-acetic acid. In the preparation of the sodium calcium complex of ethylene diamine tetraacetic acid, a solution in pyrogen-free water of the repeatedly crystallized acid is reacted with a pyrogen-free solution of 2 mols. sodium hydroxide with stirring and gentle heating, and 1 mol. calcium chloride, acetate, oxide, hydroxide carbonate &c. is then added with agitation and heating. The pH of the solution is finally brought to 7.2 to 7.4 by addition of sodium or potassium hydroxide, or of hydrochloric, citric or acetic acid.ALSO:A preparation for reducing, by base exchange, the content of toxic metal ions which may be present in the system consists of a pyrogen-free aqueous solution of an alkali metal, particularly the disodium or dipotassium, salt of a calcium chelate compound of a diamine N, N1 tetra acetic acid of pH 7.2-7.4. The solution may be injected, or taken into the body by ingestion or by skin absorption. Thus, the solution may be evaporated to dryness, and the solid incorporated in a tablet with dextrose, or gelatin-coated. Or the solution may be mixed with a water-miscible ointment to form an emulsion containing 5 per cent of the active ingredient. Diamine tetra acetic acids mentioned are ethylene diamine tetra acetic acid, trimethylene diamine tetra acetic acid, proplyene diamine tetra acetic acid, 1, 2 cyclohexylene diamino N, N1 tetra acetic acid, diethyl ether b, b1 diamino N, N1 tetra acetic acid, ethylene glycol 1, 2 ethylene ether o 1 o 1 diamino N, N1 tetra acetic acid. The preparation of the complex of ethylene diamine tetra acetic acid is described, (see Group IV(b)), the pH of the solution being finally brought to 7.2-7.4 by addition of sodium or potassium hydroxide, or of hydrochloric, citric or acetic acid.
GB6305/52A 1951-03-17 1952-03-11 Improvements in medical preparations for removing toxic heavy metals from the human body Expired GB715976A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US715976XA 1951-03-17 1951-03-17

Publications (1)

Publication Number Publication Date
GB715976A true GB715976A (en) 1954-09-22

Family

ID=22102345

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6305/52A Expired GB715976A (en) 1951-03-17 1952-03-11 Improvements in medical preparations for removing toxic heavy metals from the human body

Country Status (1)

Country Link
GB (1) GB715976A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2876159A (en) * 1957-04-12 1959-03-03 Sunderman Frederick William Dithiocarbamates for treatment of nickel poisoning
US2894023A (en) * 1956-07-12 1959-07-07 Rubin Martin Salts of the tri-ethyl ester of n-hydroxyethyl ethylene diamine triacetic acid
US3062719A (en) * 1959-10-19 1962-11-06 Geigy Chem Corp Trisodium calcium diethylenetriaminepentaacetic acid, compositions containing the same, and the use thereof
GB2368284A (en) * 2000-08-04 2002-05-01 Triox Pty Ltd Compositions comprising metal salts or complexes of ethylenediamine tetraacetic acid (EDTA) for controlling terrestrial molluscs

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2894023A (en) * 1956-07-12 1959-07-07 Rubin Martin Salts of the tri-ethyl ester of n-hydroxyethyl ethylene diamine triacetic acid
US2876159A (en) * 1957-04-12 1959-03-03 Sunderman Frederick William Dithiocarbamates for treatment of nickel poisoning
US3062719A (en) * 1959-10-19 1962-11-06 Geigy Chem Corp Trisodium calcium diethylenetriaminepentaacetic acid, compositions containing the same, and the use thereof
GB2368284A (en) * 2000-08-04 2002-05-01 Triox Pty Ltd Compositions comprising metal salts or complexes of ethylenediamine tetraacetic acid (EDTA) for controlling terrestrial molluscs

Similar Documents

Publication Publication Date Title
US4021569A (en) Method of nutritional supplementation for zinc and methionine by ingesting 1:1 zinc methionine complexes
GB1465308A (en) Composition and method for treating scours and/or tetany
GB496252A (en) Improvements relating to photographic treating solutions
US3830824A (en) Physiological organic acid silver allantoinates
GB715976A (en) Improvements in medical preparations for removing toxic heavy metals from the human body
ES360433A1 (en) Iron composition for treating anemia
Davies et al. 65. The extent of dissociation of salts in water. Part XII. Calcium salts of some amino-acids and dipeptides
GB748024A (en) Improved therapeutic preparations of iron
ES351689A1 (en) Improvements in or relating to Compositions Containing Choline Chloride
GB715848A (en) Improvements in medicinal preparations for the treatment of calcifications in human and animal systems
GB716059A (en) Improvements in medical preparations for the treatment of high blood pressure
US2434625A (en) Preparation of alkali metal ascorbates
GB613080A (en) Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
GB1033736A (en) Stable injectable protamine-active compositions
GB1250045A (en) A new water soluble derivative of erythromycin
US2466019A (en) Compositions of reduced toxicity, containing antimony and 1,2-dihydroxybenzene disulfonic acid
IE34307B1 (en) New 1-alkyl-6-azauracil compounds and preparations which contain a 1-alkyl-6-azauracil compound as an active ingredient
GB894752A (en) Improvements in or relating to citric acid derivatives
US2098976A (en) Medicinal preparations containing metal compounds of decomposition products of nucleoproteins
GB770075A (en) Improvements in or relating to preparation of a fibrinogen product and stable solutions thereof
GB748823A (en) Improvements in or relating to hair treating preparations
US2562865A (en) Theobromine alkaline earth metal levulinates
GB1032173A (en) A method of stabilising aqueous solutions of tin ú¿óú® salts, and dental preparations containing such stabilised solutions
GB1390524A (en) Hydroxyquinoline derivative
GB1172470A (en) A Novel Imidazole Compound and a Process for Producing the same